910 filings
Page 24 of 46
10-Q
2015 Q2
ARMP
Armata Pharmaceuticals, Inc.
Quarterly report
13 Aug 15
12:00am
4
ARMP
Armata Pharmaceuticals, Inc.
6 Aug 15
AmpliPhi Biosciences / Michael Scott Salka ownership change
12:00am
SC 13E3/A
ARMP
Armata Pharmaceuticals, Inc.
4 Aug 15
Going private transaction (amended)
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
4 Aug 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
4 Aug 15
Amendments to Articles of Incorporation or Bylaws
12:00am
UPLOAD
ARMP
Armata Pharmaceuticals, Inc.
15 Jul 15
Letter from SEC
12:00am
DEF 14A
ARMP
Armata Pharmaceuticals, Inc.
Definitive proxy
10 Jul 15
12:00am
CORRESP
ARMP
Armata Pharmaceuticals, Inc.
2 Jul 15
Correspondence with SEC
12:00am
UPLOAD
ARMP
Armata Pharmaceuticals, Inc.
1 Jul 15
Letter from SEC
12:00am
UPLOAD
ARMP
Armata Pharmaceuticals, Inc.
1 Jul 15
Letter from SEC
12:00am
PRER14A
ARMP
Armata Pharmaceuticals, Inc.
24 Jun 15
Preliminary revised proxy
12:00am
CORRESP
ARMP
Armata Pharmaceuticals, Inc.
24 Jun 15
Correspondence with SEC
12:00am
UPLOAD
ARMP
Armata Pharmaceuticals, Inc.
15 Jun 15
Letter from SEC
12:00am
SC 13E3
ARMP
Armata Pharmaceuticals, Inc.
2 Jun 15
Going private transaction
12:00am
UPLOAD
ARMP
Armata Pharmaceuticals, Inc.
26 May 15
Letter from SEC
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
22 May 15
AmpliPhi Provides Corporate Update and Reports First Quarter 2015 Financial Results
12:00am
424B3
ARMP
Armata Pharmaceuticals, Inc.
15 May 15
Prospectus supplement
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
15 May 15
Entry into a Material Definitive Agreement
12:00am
10-Q
2015 Q1
ARMP
Armata Pharmaceuticals, Inc.
Quarterly report
15 May 15
12:00am
PRE 14A
ARMP
Armata Pharmaceuticals, Inc.
Preliminary proxy
15 May 15
12:00am